<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Stopping power monitoring during proton therapy by means of prompt gamma timing: first experimental results with a homogeneous phantom - Health AI Hub</title>
    <meta name="description" content="This paper introduces Spatiotemporal Emission Reconstruction from Prompt-Gamma Timing (SER-PGT) as a promising method to monitor proton therapy in real-time, pr">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Stopping power monitoring during proton therapy by means of prompt gamma timing: first experimental results with a homogeneous phantom</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2511.21344v1" target="_blank">2511.21344v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-11-26
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Julius Werner, Francesco Pennazio, Piergiorgio Cerello, Elisa Fiorina, Simona Giordanengo, Felix Mas Milian, Alessio Mereghetti, Franco Mostardi, Marco Pullia, Sahar Ranjbar, Roberto Sacchi, Anna Vignati, Magdalena Rafecas, Veronica Ferrero
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> physics.med-ph
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.95 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2511.21344v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2511.21344v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This paper introduces Spatiotemporal Emission Reconstruction from Prompt-Gamma Timing (SER-PGT) as a promising method to monitor proton therapy in real-time, providing crucial insights into particle range and stopping power. Initial experimental results, using a 226.9 MeV proton beam on a homogeneous phantom at sub-clinical intensity, demonstrate the feasibility of SER-PGT. The method achieved an 8% error in stopping power estimation and successfully identified range shifts with a 3 mm standard deviation.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This research is crucial for enhancing the precision of proton therapy by enabling real-time monitoring of dose delivery. Reducing uncertainties in proton range and stopping power allows for more accurate and adaptive treatment planning, leading to optimized tumor control and minimized damage to surrounding healthy tissues.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>The abstract describes a method involving data acquisition from detectors and subsequent reconstruction to estimate physical parameters. While such reconstruction tasks can sometimes leverage AI/machine learning, this abstract does not explicitly mention the use of artificial intelligence, machine learning, or deep learning as part of the SER-PGT method or its application. Therefore, it is not explicitly an AI health application based on the provided text.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Proton therapy's full potential is hampered by uncertainties in dose distribution, necessitating advanced monitoring techniques for adaptive treatment planning.</li>
                    
                    <li>SER-PGT is proposed as a novel method to provide real-time information on particle range and stopping power, overcoming the challenge of direct measurement of patient tissue properties.</li>
                    
                    <li>The experimental setup involved a 226.9 MeV synchrotron-proton beam impinging on a homogeneous phantom at a sub-clinical intensity (2 - 4 x 10^7 pps).</li>
                    
                    <li>A multi-detector system comprising a thin, segmented Low Gain Avalanche Diode (LGAD) for proton detection and Lanthanum Bromide (LaBr3)-based crystals for prompt gamma detection was utilized.</li>
                    
                    <li>The estimated stopping power profile showed an 8% ¬± 3% average error compared to NIST PSTAR values and a 2% ¬± 2% deviation relative to water at 100 MeV.</li>
                    
                    <li>Range assessment in a phantom featuring a 4 cm air-gap successfully identified the range shift with a 3 mm standard deviation.</li>
                    
                    <li>These results confirm the feasibility of SER-PGT to concurrently recover both range and stopping power information by leveraging particle kinematics and prompt gamma timing measurements.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The study employed a 226.9 MeV synchrotron-proton beam at a sub-clinical intensity (2 - 4 x 10^7 pps) directed at a homogeneous phantom. The SER-PGT method utilized a multi-detector setup: a segmented Low Gain Avalanche Diode (LGAD) for proton detection and Lanthanum Bromide (LaBr3)-based crystals for prompt gamma photon detection. Data from these detectors were processed to reconstruct spatiotemporal emission profiles, allowing for the determination of proton range and stopping power.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The estimated stopping power profile achieved an 8% ¬± 3% average error compared to NIST PSTAR values and a 2% ¬± 2% deviation relative to water at 100 MeV. Range assessment in a phantom with a 4 cm air-gap successfully identified the expected range shift with a 3 mm standard deviation, demonstrating the method's capability to recover both range and stopping power information.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>The ability of SER-PGT to provide real-time, in-situ monitoring of proton range and stopping power directly addresses a major limitation in current proton therapy. This breakthrough can enable truly adaptive proton therapy, allowing clinicians to dynamically adjust treatment plans during therapy to account for patient anatomical changes or setup errors, thereby maximizing dose conformity to the tumor and significantly improving treatment outcomes and patient safety.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The experiments were conducted at a sub-clinical proton beam intensity and utilized a homogeneous phantom. Further validation is required at clinically relevant intensities and with more complex, heterogeneous phantoms or in-vivo conditions to fully assess its clinical applicability.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>Future research should focus on validating SER-PGT at clinical proton beam intensities and applying the methodology to heterogeneous phantoms, and eventually in-vivo. Further advancements in detector technology and reconstruction algorithms will be essential to improve accuracy, spatial resolution, and temporal performance for integration into clinical adaptive proton therapy workflows.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Radiation Oncology</span>
                    
                    <span class="tag">Medical Physics</span>
                    
                    <span class="tag">Cancer Therapy</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">proton therapy</span>
                    
                    <span class="tag tag-keyword">prompt gamma timing</span>
                    
                    <span class="tag tag-keyword">stopping power</span>
                    
                    <span class="tag tag-keyword">range monitoring</span>
                    
                    <span class="tag tag-keyword">adaptive radiotherapy</span>
                    
                    <span class="tag tag-keyword">particle kinematics</span>
                    
                    <span class="tag tag-keyword">medical physics</span>
                    
                    <span class="tag tag-keyword">radiation oncology</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Proton therapy's full potential is limited by uncertainties that prevent optimal dose distribution. Monitoring techniques can reduce these uncertainties and enable adaptive treatment planning. Spatiotemporal Emission Reconstruction from Prompt-Gamma Timing (SER-PGT) is a promising method that provides insights into both particle range and stopping power, whose calculation would normally require knowledge about patient tissue properties that cannot be directly measured. We present the first experimental results using a 226.9 MeV synchrotron-proton beam impinging on a homogeneous phantom at a sub-clinical intensity (2 - 4 x 10^7 pps). SER-PGT uses data from a multi-detector setup: a thin and segmented Low Gain Avalanche Diode for proton detection and Lanthanum Bromide-based crystals for photon detection. The estimated stopping power profile showed an 8% +- 3% average error compared to NIST PSTAR values, and 2% +- 2% deviation relative to water at 100 MeV. Range assessment in a phantom with a 4 cm air-gap successfully identified the range shift with a 3 mm standard deviation. These results demonstrate the feasibility of using SER-PGT to recover both range and stopping power information through particle kinematics and PGT measurements.</p>
            </section>

            
            <section class="paper-section">
                <h2>Comments</h2>
                <p>15 pages, 6 figures</p>
            </section>
            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>